Publicaciones en las que colabora con Gemma Quincoces Fernández (28)

2023

  1. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

    Scientific Reports, Vol. 12, Núm. 1

  2. Preclinical safety of negatively charged microspheres (NCMs): Optimization of radiolabeling for in vivo and ex vivo biodistribution studies after topical administration on full-thickness wounds in a rat model

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 177, pp. 61-67

2021

  1. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

2020

  1. Preparation, radiolabeling with 99mTc and 67Ga and biodistribution studies of albumin nanoparticles covered with polymers

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 39, Núm. 4, pp. 225-232

2019

  1. Mannosylated Nanoparticles for Oral Immunotherapy in a Murine Model of Peanut Allergy

    Journal of Pharmaceutical Sciences, Vol. 108, Núm. 7, pp. 2421-2429

  2. Modulation of the fate of zein nanoparticles by their coating with a Gantrez® AN-thiamine polymer conjugate

    International Journal of Pharmaceutics: X, Vol. 1

  3. Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

    International Journal of Pharmaceutics, Vol. 569

  4. The effect of thiamine-coating nanoparticles on their biodistribution and fate following oral administration

    European Journal of Pharmaceutical Sciences, Vol. 128, pp. 81-90

2018

  1. Increased oral bioavailability of resveratrol by its encapsulation in casein nanoparticles

    International Journal of Molecular Sciences, Vol. 19, Núm. 9

2017

  1. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: Is PET imaging of pancreatic beta cell mass feasible?

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 447-455

2015

  1. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 97, pp. 280-289

  2. Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [18F]-tetrafluoroborate

    EJNMMI Research, Vol. 5, Núm. 1, pp. 1-9

  3. Zein nanoparticles for oral folic acid delivery

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 450-457

2013

  1. Radiolabeling and biodistribution studies of polymeric nanoparticles as adjuvants for ocular vaccination against brucellosis

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 2, pp. 92-97

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

  3. Radiofármacos para estudios PET

    Medicina nuclear en la práctica clínica (Aula Médica Ediciones), pp. 83-100

2011

  1. Molecular imaging techniques to study the biodistribution of orally administered 99mTc-labelled naive and ligand-tagged nanoparticles

    Molecular Imaging and Biology, Vol. 13, Núm. 6, pp. 1215-1223

2010

  1. Design and performance evaluation of single-use whole-sterile "plug & play" kits for routine automated production of [11C]choline and [11C]methionine with radiopharmaceutical quality

    Applied Radiation and Isotopes, Vol. 68, Núm. 12, pp. 2298-2301